LCMS Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 4 - Multiplex Analysis -
Applications | 2017 | ShimadzuInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
IndustriesPharma & Biopharma
ManufacturerShimadzu
Key wordsmultiplex, antibody, structure, nsmol, confirmation, quantitation, brentuximab, cetuximab, rituximab, drugs, mrm, nsmoltm, vedotin, analysis, plasma, human, proteolysis, chromatograms, news, accuracy, shimadzu, asgytftsy, sgipar, vliyaasnle, average, antibodies, nmhwvk, precision, sqvffk, set, peptides, single, peptide, selective, chief, variety, selection, kit, concentration, fulfilled, paradigm, drug, fab, issued, many, data, guideline, reflect, gas, multiple
Similar PDF
LCMS Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 4 - Multiplex Analysis -
2017|Shimadzu|Applications
LAAN-A-LM-E119A Application News No. C148A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using FabSelective Proteolysis nSMOL - Part 4 - Multiplex Analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…
Key words
multiplex, multiplexantibody, antibodystructure, structurensmol, nsmolconfirmation, confirmationquantitation, quantitationbrentuximab, brentuximabcetuximab, cetuximabrituximab, rituximabdrugs, drugsmrm, mrmnsmoltm, nsmoltmvedotin, vedotinanalysis, analysisplasma
Shimadzu Solutions for Biopharmaceutical - Application Notebook
2018|Shimadzu|Guides
C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…
Key words
acid, acidamino, aminoantibody, antibodyglycan, glycannsmol, nsmolerexim, ereximstructure, structurenews, newsaggregates, aggregatesnucleic, nucleicanalysis, analysismrm, mrmglycans, glycanssizer, sizeraggregate
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis -
2017|Shimadzu|Applications
LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…
Key words
antibody, antibodybevacizumab, bevacizumabconfirmation, confirmationstructure, structurequantitation, quantitationnsmol, nsmolhuman, humanmrm, mrmaccuracy, accuracyftfsldtsk, ftfsldtsknsmoltm, nsmoltmdrugs, drugsplasma, plasmaproteolysis, proteolysisaverage
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis
2017|Shimadzu|Applications
LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…
Key words
antibody, antibodybevacizumab, bevacizumabconfirmation, confirmationstructure, structurequantitation, quantitationnsmol, nsmolhuman, humanaccuracy, accuracymrm, mrmftfsldtsk, ftfsldtsknsmoltm, nsmoltmplasma, plasmaproteolysis, proteolysisdrug, drugaverage